Publish in this journal
Journal Information

Statistics

Follow this link to access the full text of the article

Original Article
A cost-consequence analysis of the preferential use of secukinumab versus adalimumab for the treatment of psoriatic arthritis
Análisis de las consecuencias en materia de costos del uso preferencial del secukinumab en comparación con el adalimumab para el tratamiento de la artritis psoriásica
Alberto Jiménez-Moralesa, Rafael Cáliza, Susana Aceitunob, Miriam Pradesb, Carles Blanchc,
Corresponding author
carles.blanch@novartis.com

Corresponding author.
a Virgen de las Nieves University Hospital, Granada, Spain
b Outcomes’10, Castellón de la Plana, Spain
c Novartis Pharmaceuticals, Novartis Farmacéutica, Barcelona, Spain
Read
63
Times
was read the article
37
Total PDF
17
Total HTML
9
Total EPUB
Share statistics
Article information
ISSN: 21735743
Original language: English
The statistics are updated each day
Year/Month Html Pdf Epub Total
2022 May 17 35 9 61
2022 April 0 0 0 0
2022 March 0 0 0 0
2022 February 0 2 0 2
2022 January 0 0 0 0
2021 December 0 0 0 0
2021 November 0 0 0 0
2021 October 0 0 0 0

Follow this link to access the full text of the article

Idiomas
Reumatología Clínica (English Edition)

Subscribe to our newsletter

es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?